Literature DB >> 10607697

Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins.

P Gupta1, T R Oegema, J J Brazil, A Z Dudek, A Slungaard, C M Verfaillie.   

Abstract

We have shown that stromal O-sulfated heparan sulfate glycosaminoglycans (O-S-GAGs) regulate primitive human hematopoietic progenitor cell (HPC) growth and differentiation by colocalizing heparin-binding cytokines and matrix proteins with HPC in stem cell "niches" in the marrow microenvironment. We now show that long-term culture-initiating cells (LTC-IC) are maintained for 5 weeks in the absence of stroma when O-S-GAGs are added to IL-3 and either MIP-1alpha or PF4 (LTC-IC maintenance without GAGs, 32 +/- 2%; with GAGs, 95 +/- 7%; P <.001). When cultured with 5 additional cytokines, O-S-GAGs, IL-3, and MIP-1alpha, LTC-IC expanded 2- to 4-fold at 2 weeks, and 92 +/- 8% LTC-IC were maintained at 5 weeks. Similar results were seen when PF4 replaced MIP-1alpha. Although O-S-GAG omission did not affect 2-week expansion, only 20% LTC-IC were maintained for 5 weeks. When O-S-heparin was replaced by completely desulfated-, N-sulfated (O-desulfated), or unmodified heparins, LTC-IC maintenance at week 5 was not better than with cytokines alone. Unmodified- and O-S-heparin, but not desulfated- or N-sulfated heparin, bound to MIP-1alpha, IL-3, PF4, VEGF, thrombospondin, and fibronectin. However, the affinity of heparin for thrombospondin and PF4, and the association and dissociation rates of heparin for PF4, were higher than those of O-S-heparin. We conclude that (i) although cytokines may suffice to induce early expansion, adult human LTC-IC maintenance for longer than 1 month requires O-S-GAGs, and (ii) HPC support may depend not only on the ability of GAGs to bind proteins, but also on optimal affinity and kinetics of interactions that affect presentation of proteins in a biologically active manner to progenitors. (Blood. 2000;95:147-155)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10607697

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Effects of platelet factor 4 on expression of bone marrow heparan sulfate in syngenic bone marrow transplantation mice.

Authors:  Fankai Meng; Hanying Sun; Wenli Liu; Huiling Yuan; Huizhen Xu; Lan Sun; Yinli Zhou; Tianhua Ren
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

2.  The effect of human bone marrow stroma-derived heparan sulfate on the ex vivo expansion of human cord blood hematopoietic stem cells.

Authors:  Diah S Bramono; David A Rider; Sadasivam Murali; Victor Nurcombe; Simon M Cool
Journal:  Pharm Res       Date:  2010-12-24       Impact factor: 4.200

3.  Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development.

Authors:  M A Baxter; R F Wynn; L Schyma; D K Holmes; J E Wraith; L J Fairbairn; I Bellantuono
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

4.  Differential effects of HOXB4 and NUP98-HOXA10hd on hematopoietic repopulating cells in a nonhuman primate model.

Authors:  Korashon L Watts; Xiaobing Zhang; Brian C Beard; Sum Ying Chiu; Grant D Trobridge; R Keith Humphries; Hans-Peter Kiem
Journal:  Hum Gene Ther       Date:  2011-09-06       Impact factor: 5.695

5.  Covalently immobilized glycosaminoglycans enhance megakaryocyte progenitor expansion and platelet release.

Authors:  Vipuil Kishore; James F Eliason; Howard W T Matthew
Journal:  J Biomed Mater Res A       Date:  2011-01-25       Impact factor: 4.396

6.  Effects of simian betaretrovirus serotype 1 (SRV1) infection on the differentiation of hematopoietic progenitor cells (CD34+) derived from bone marrow of rhesus macaques (Macaca mulatta).

Authors:  Nestor A Montiel; Patricia A Todd; JoAnn Yee; Nicholas W Lerche
Journal:  Comp Med       Date:  2012-02       Impact factor: 0.982

7.  Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells.

Authors:  Chendong Pan; Matthew S Nelson; Morayma Reyes; Lisa Koodie; Joseph J Brazil; Elliot J Stephenson; Robert C Zhao; Charles Peters; Scott B Selleck; Sally E Stringer; Pankaj Gupta
Journal:  Blood       Date:  2005-06-09       Impact factor: 22.113

Review 8.  The extracellular matrix of hematopoietic stem cell niches.

Authors:  Cornelia Lee-Thedieck; Peter Schertl; Gerd Klein
Journal:  Adv Drug Deliv Rev       Date:  2021-11-25       Impact factor: 15.470

9.  Syndecan-2 enriches for hematopoietic stem cells and regulates stem cell repopulating capacity.

Authors:  Christina M Termini; Amara Pang; Michelle Li; Tiancheng Fang; Vivian Y Chang; John P Chute
Journal:  Blood       Date:  2022-01-13       Impact factor: 22.113

10.  Distinct Bone Marrow Sources of Pleiotrophin Control Hematopoietic Stem Cell Maintenance and Regeneration.

Authors:  Heather A Himburg; Christina M Termini; Lauren Schlussel; Jenny Kan; Michelle Li; Liman Zhao; Tiancheng Fang; Joshua P Sasine; Vivian Y Chang; John P Chute
Journal:  Cell Stem Cell       Date:  2018-08-09       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.